Transient global ischemia in rats yields striatal projection neuron and interneuron loss resembling that in Huntington's disease

Experimental Neurology

Volumn 166, Issue 2, 2000, Pages 307-323

  Meade, C A ^a   Figueredo Cardenas, G ^a   Fusco, F ^b   Nowak Jr , T S ^a   Pulsinelli, W A ^a   Reiner, A ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b IRCCS FONDAZIONE SANTA LUCIA   (Italy)

Author keywords

Basal ganglia; CHAT; Enkephalin; Global ischemia; Huntington's disease; Rat; Somatestatin; Substance P

Indexed keywords

NICOTINAMIDE ADENINE DINUCLEOTIDE; PARVALBUMIN; SOMATOSTATIN; SUBSTANCE P;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASAL GANGLION; BRAIN ISCHEMIA; CELL SURVIVAL; CHOLINERGIC NERVE CELL; CONTROLLED STUDY; HUNTINGTON CHOREA; INTERNEURON; MALE; NERVE PROJECTION; NONHUMAN; PERIKARYON; PRIORITY JOURNAL; RAT; STRIATE CORTEX;

EID: 0033674375     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.2000.7530     Document Type: Article

References (125)

1. Alternative excitotoxic hypotheses
2. Preferential loss of striato-external pallidal projection neurons in presymptomatic Huntington's disease
3. Striatal and nigral neuron subpopulations in rigid Huntington's disease: Implications for the functional anatomy of chorea and rigidity-akinesia
4. Abnormalities of striatal projection neurons and N-methyl-D-aspartate receptors in presymptomatic Huntington's disease
5. Distribution and relative abundance of neurons in the pigeon forebrain containing somatostatin, neuropeptide Y, or both
6. Extensive co-occurrence of substance P and dynorphin in striatal projection neurons: An evolutionarily conserved feature of basal ganglia organization
7. Huntington's disease: Changes in tachykinin content in postmortem brains
8. Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid
9. A detailed examination of substance P in pathologically graded cases of Huntington's disease
10. Chronic quinolinic acid lesions in rats closely resemble Huntington's disease
11. Do defects in mitochondrial energy metabolism underlie the pathology of neurodegenerative diseases?
12. Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid
13. Differential sparing of somatostatin-neuropeptide Y and cholinergic neurons following striatal excitotoxin lesions
14. Somatostatin and neuropeptide Y concentrations in pathologically graded cases of Huntington's disease
15. Aminooxyacetic acid results in excitotoxin lesions by a novel indirect mechanism
16. Cellular, subcellular, and subsynaptic distribution of AMPA-type glutamate receptor subunits in the neostriatum of the rat
17. Classical transmitters in the CNS
18. Systemic 3-nitropropionic acid: Behavioral deficits and striatal damage in adult rats
19. Partial inhibition of brain succinate dehydrogenase by 3-nitropropionic acid is sufficient to initiate striatal degeneration in rat
20. Chronic mitochondrial energy impairment produces selective striatal degeneration and abnormal choreiform movements in primates
21. Huntington's chorea. Historical, clinical and laboratory synopsis
22. Reduction in basal ganglia and substantia nigra substance P levels in Huntington's disease
23. Huntingtin and DRPLA proteins selectively interact with the enzyme GAPDH
24. Relative loss of the striatal striosome compartment, defined by calbindin-D28k immunostaining, following developmental hypoxic-ischemic injury
25. Quantitative morphological analysis of striatal cholinergic neurons in perinatal asphyxia
26. The effect of neonatal hypoxia-ischemia on striatal cholinergic neuropil: A quantitative morphologic analysis
27. Calbindin D-28k and parvalbumin in the rat nervous system
28. Monoclonal antibodies directed against the calcium binding protein parvalbumin
29. Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human Huntington disease gene
30. Cellular distribution of the NMDA receptor NR2A/2B subunits in the rat striatum
31. Evidence for the preferential localization of GluR1 subunits of AMPA receptors to the dentritic spines of medium spiny neurons in rat striatum
32. Ischemic damage in the striatum of adult gerbils: Relative sparing of somatostatinergic and cholinergic interneurons contrasts with loss of efferent neurons
33. The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death
34. No evidence for preservation of somatostatin-containing neurons after intrastriatal injections of quinolinic acid
35. Sparing of cholinergic neurons following quinolinic acid lesions of the rat striatum
36. Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation
37. Excitotoxic injury of the neostriatum: A model for Huntington's disease
38. Parvalbumin-immunoreactive neurons in the cerebral cortex in Huntington's disease
39. Sparing of acetylcholinesterase-containing striatal neurons in Huntington's disease
40. Selective sparing of a class of striatal neurons in Huntington's disease
41. Selective sparing of NADPH-diaphorase neurons in neonatal hypoxia-ischemia
42. Relative survival of striatal projection neurons and interneurons after intrastriatal injection of quinolinic acid in rats
43. Age-dependent differences in survival of striatal somatostatin-NPY-NADPH-diaphorase-containing interneurons versus striatal projection neurons after intrastriatal injection of quinolinic acid in rats
44. Relative resistance of striatal neurons containing calbindin or parvalbumin to quinolinic acid-mediated excitotoxicity compared to other striatal neuron types
45. Colocalization of somatostatin, neuropeptide Y, neuronal nitric oxide synthase and NADPH-diaphorase in striatal interneurons in rats
46. The striato-entopeduncular pathway in the rat. A retrograde transport study with wheatgerm-agglutinin-horseradish peroxidase
47. Chronic infusion of quinolinic acid in rat striatum: Effects on discrete neuronal populations
48. The response of GABAergic and cholinergic neurons to transient cerebral ischemia
49. Relationship of neuronal vulnerability and calcium binding protein immunoreactivity in ischemia
50. 3-Nitropropionic acid produces indirect excitotoxic damage to rat striatum
51. Cellular localization of huntingtin in striatal and cortical neurons in rats: Lack of correlation with neuronal vulnerability in Huntington's disease
52. Relative sparing of GABAergic interneurons in the striatum of gerbils with ischemia-induced lesions
53. Serial changes of cerebral glucose metabolism and caudate size in persons at risk for Huntington's disease
54. Neurotransmitters and neuromodulators in the basal ganglia
55. Inhibition of succinate dehydrogenase by malonic acid produces an 'excitotoxic' lesion in rat striatum
56. An experimental electron microscopic study on the striatonigral projection in the cat
57. Quantifiable bradykinesia, gait abnormalities and Huntington's disease-like striatal lesions in rats chronically treated with 3-nitropropionic acid
58. Paravalbumin immunoreactive neurons resist degeneration in Huntington's disease striatum
59. Neurodegenerative disorders: Clues from glutamate and energy metabolism
60. Mapping of the colocalization of calretinin and tyrosine hydroxylase in the rat substantia nigra and ventral tegmental area
61. Monoclonal antibodies and polyvalent antiserum to chicken choline acetyltransferase
62. Effects of postnatal hypoxia-ischemia on cholinergic neurons in the developing rat forebrain: Choline acetyltransferase immunocytochemistry
63. Substance P: Decrease in substantia nigra and globus pallidus in Huntington's disease
64. Studies on neurotransmitter markers and striatal neuronal cell density in Huntington's disease and dentatorubropallidoluysian atrophy
65. Projection subtypes of rat neostriatal matrix cells revealed by intracellular injection of biocytin
66. Glutamate decarboxylase immunoreactive neurons in rat neostriatum: Their morphological types and populations
67. Parvalbumin-immunoreactive neurons in the rat neostriatum: A light and electron microscopic study
68. Comparison of ibotenate and kainate neurotoxicity in rat brain: A histological study
69. Pattern of cell loss in Huntington's disease
70. Is there a selectivity of neuronal degeneration induced by intrastriatal injection of kainic acid?
71. NMDA receptor subunit mRNA expression by projection neurons and interneurons in rat striatum
72. Input from the frontal cortex and the parafascicular nucleus to cholinergic interneurons in the dorsal striatum of the rat
73. Cortical input to parvalbumin-immunoreactive neurones in the putamen of the squirrel monkey
74. Saccades in Huntington's disease: Initiation defects and distractibility
75. Enhanced sensitivity to N-methyl-D-aspartate receptor activation in transgenic and knockin mouse models of Huntington's disease
76. Excitatory amino acids as a final common pathway for neurologic disorders
77. Organization of the striatum: Collateralization of its efferent axons
78. Intrastriatal dopamine injection induces apoptosis through oxidation-involved activation of transcription factors AP-1 and NF-kappaB in rats
79. Repeated asphyxia causes loss of striatal projection neurons in the fetal sheep brain
80. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice
81. Huntington's disease: New approaches to an old problem. The Robert Wartenberg lecture
82. Huntington's disease. Pathogenesis and management
83. AMPA glutamate receptor subunits are differentially distributed in rat brain
84. Differential abundance of superoxide dismutase in interneurons versus projection neurons and in matrix versus striosome neurons in monkey striatum
85. Glutamate becomes neurotoxic via the N-methyl-D-aspartate receptor when intracellular energy levels are reduced
86. Chronic 3-nitropropionic acid treatment in baboons replicates the cognitive and motor deficits of Huntington's disease
87. Glutamate excitotoxicity in transient global cerebral ischemia
88. Excitatory amino acid release and free radical formation may cooperate in the genesis of ischemia-induced neuronal damage
89. Light and electron immunocytochemical localization of AMPA-selective glutamate receptors in the rat brain
90. Comparative morphology of the substantia nigra and ventral tegmental area in the monkey, cat and rat
91. A new model of bilateral hemispheric ischemia in the unanesthetized rat
92. Temporal profile of neuronal damage in a model of transient forebrain ischemia
93. Effects of quinolinic acid on messenger RNAs encoding somatostatin and glutamic acid decarboxylases in the striatum of adult rats
94. Compartmental origin of the striato-entopeduncular projection in the rat
95. The distribution of proenkephalin-derived peptides in the central nervous system of turtles
96. Catecholaminergic innervation of the basal ganglia in mammals
97. Differential loss of striatal projection neurons in Huntington disease
98. The patterns of neurotransmitter and neuropeptide co-occurrence among striatal projection neurons: Conclusions based on recent findings
99. Brain GABA levels in asymptomatic Huntington's disease
100. Selective vulnerability in Huntington's disease: Preferential loss of cannabinoid receptors in lateral globus pallidus
101. Preferential loss of preproenkephalin versus preprotachykinin neurons from the striatum of Huntington's disease patients
102. Colocalization of somatostatin, neuropeptide Y, and NADPH-diaphorase in the caudate-putamen of the rat
103. Differential distribution of nicotinamide adenine dinucleotide phosphate-diaphorase and neural nitric oxide synthase in the rat choroid plexus. A histochemical and immunocytochemical study
104. Evidence for a preferential loss of enkephalin immunoreactivity in the external globus pallidus in low grade Huntington's disease using high resolution image analysis
105. The differential expression patterns of messenger RNAs encoding non-N-methyl-D-aspartate glutamate receptor subunits (GluR1-4) in the rat brain
106. Differential vulnerability of central neurons of the rat to quinolinic acid
107. Opioid peptides in Huntington's disease: Alterations in prodynorphin and proenkephalin system
108. Huntington's disease. A decade of progress
109. Neurochemical alterations in Huntington's chorea: A study of post-mortem brain tissue
110. A disorder of rapid eye movements in Huntington's chorea
111. Neurochemical substrates of rigidity and chorea in Huntington's disease
112. Localization of AMPA-selective excitatory amino acid receptor subunits in identified populations of striatal neurons
113. Splice variants of glutamate receptor subunits 2 and 3 in striatal projection neurons
114. Selective sparing of NADPH-diaphorase-somatostatin-neuropeptide Y neurons in ischemic gerbil striatum
115. NADPH-diaphorase: A selective histochemical marker for the cholinergic neurons of the pontine reticular formation
116. 3-Nitropropionic acid induces a spectrum of Huntington's disease-like neuropathology in rat striatum
117. Differential sensitivity of calbindin and parvalbumin immunoreactive cells in the striatum to excitotoxins
118. Morphology and synaptic connections of crossed corticostriatal neurons in the rat
119. NMDA receptor losses in putamen from patients with Huntington's disease
120. Normal caudate glucose metabolism in persons at risk for Huntington's disease
121. Huntington's disease in Venezuela: Neurologic features and functional decline